Abdominal Pain in Inflammatory Bowel Disease-Epidemiology, Pathophysiology, and Management: A Narrative Review.

IF 4.1 2区医学 Q1 CLINICAL NEUROLOGY Pain and Therapy Pub Date : 2024-12-01 Epub Date: 2024-10-28 DOI:10.1007/s40122-024-00672-9

Wei-Wei Tan, Zi-Xuan Liu, Xiao-Yan Liu, Wei-Bing Zhang, Lie Zheng, Ya-Li Zhang, Yan-Cheng Dai

引用次数: 0

Abstract

Abdominal pain is a major symptom of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, and has a significant impact on patients' quality of life. Given the evolving understanding of IBD pathology and management strategies, there is an urgent need to review the recent research findings. In this review, we have analyzed the epidemiology, pathophysiology, and management of abdominal pain in IBD over the past decade. We draw on the current literature and highlight emerging trends, challenges, and advances in this field. By synthesizing key findings, this review provides insights into the complex interplay between abdominal pain, disease progression, and therapeutic interventions for IBD.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

炎症性肠病中的腹痛--流行病学、病理生理学和治疗：叙述性综述。

腹痛是包括克罗恩病和溃疡性结肠炎在内的炎症性肠病（IBD）的主要症状，对患者的生活质量有很大影响。鉴于人们对 IBD 病理和治疗策略的认识在不断发展，因此迫切需要对近期的研究成果进行综述。在这篇综述中，我们分析了过去十年中 IBD 腹痛的流行病学、病理生理学和治疗方法。我们借鉴了当前的文献，并强调了这一领域新出现的趋势、挑战和进展。本综述通过对主要研究结果的归纳，深入探讨了腹痛、疾病进展和 IBD 治疗干预之间复杂的相互作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Pain and Therapy CLINICAL NEUROLOGY-

CiteScore

6.60

自引率

5.00%

发文量

110

审稿时长

6 weeks

期刊介绍： Pain and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of pain therapies and pain-related devices. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to, acute pain, cancer pain, chronic pain, headache and migraine, neuropathic pain, opioids, palliative care and pain ethics, peri- and post-operative pain as well as rheumatic pain and fibromyalgia. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, short communications such as commentaries and editorials, and letters. The journal is read by a global audience and receives submissions from around the world. Pain and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.